GNRSU The Greenrose Holding Co. (PNK) $0.000001 on 23 Mar 2026: risk view

GNRSU stock fell to $0.000001 on 23 Mar 2026, down 99.99933% from the prior close. The Greenrose Holding Company Inc. (GNRSU) trades on the PNK exchange in the United States and shows extremely low liquidity with volume 145.00. Investors should note the contrast between the current quote and the recent average price near $0.15 and reassess position sizing and risk.

GNRSU stock: market move and price data

The Greenrose Holding Company Inc. (GNRSU) is quoted at $0.000001 USD on the PNK exchange in the United States. Today’s trade shows change -0.149999 from the previous close of $0.15, a -99.99933% move with volume 145.00. Year high is $0.15 and year low is $0.000001. Market cap is listed as $13.00 USD and shares outstanding are 12,853,627.00.

What likely drove the GNRSU stock drop

There is no recent earnings release tied to today’s decline; the company’s earnings announcement field is null. The price gap from $0.15 to $0.000001 suggests a liquidity shock, microcap trading imbalance, or corporate action rather than an EPS surprise. GNRSU’s industry classification is Drug Manufacturers – Specialty & Generic, and sector pressure on small cannabis names can amplify sharp moves in low-volume listings.

GNRSU stock: financials and valuation snapshot

Key trailing metrics show EPS 3.10 and a reported PE near 0.0000003, reflecting the extreme mismatch between accounting earnings and market price. Revenue per share TTM is 1.58, book value per share is 4.30, and cash per share is 0.56. Liquidity ratios are weak: current ratio 0.21 and cash ratio 0.06. Debt to equity is 1.57 and days of inventory on hand is 439.24, underlining working capital strain.

Meyka AI rates GNRSU with a score out of 100 and technical view

Meyka AI rates GNRSU with a score out of 100: 66.93 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry performance, financial growth, key metrics, and analyst consensus. Technical averages show a 50-day and 200-day price average at $0.15, highlighting the disconnect between historical averages and today’s quote of $0.000001.

GNRSU stock price targets and analyst scenarios

Scenario-based targets for GNRSU reflect wide uncertainty. Bear case: $0.000001 USD (current quote) if liquidity dries or delisting risks intensify. Base case: $0.02 USD in 12 months if operations stabilize and market interest returns. Bull case: $0.10 USD if the company reports a meaningful operational turnaround or consolidation in cannabis specialty manufacturing. These are scenario targets, not buy or sell recommendations.

Trading risks, liquidity and regulatory notes

Low volume 145.00 and market cap $13.00 USD create extreme execution risk for GNRSU stock. The PNK listing and microcap status increase the chance of wide spreads, stale prints, and potential delisting. Investors should consider position limits and the high volatility typical for small cannabis and specialty drug manufacturers in the United States.

Final Thoughts

Key takeaways on GNRSU stock: the quote at $0.000001 USD on 23 Mar 2026 represents an almost complete market-value wipeout from the previous $0.15 close. Meyka AI’s forecast model projects $0.00 over the near term, implying an approximate -100.00% change versus the current market quote. That forecast is a model-based projection and not a guarantee. Our scenario targets present a wide range: bear $0.000001, base $0.02, bull $0.10, reflecting thin liquidity, elevated balance sheet risk, and the cannabis sector backdrop. Financial metrics show EPS 3.10 and a current ratio 0.21, flagging working capital pressure. For PNK-listed microcaps like GNRSU, risk management and small position sizing are essential. Meyka AI provides this as AI-powered market analysis and not investment advice; always verify corporate filings and exchange notices before trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.